INSIGHTS ON CLINICAL TRIAL PARTNERING

• Enhancing Clinical Trial Flexibility

  Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.

• How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs

  Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.

• Central eSource Is The Latest In Sponsor Provided Site Offerings

  For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.

• Rethinking Trial Access Through Trust-Driven Design And Local Collaboration

  Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.

• From Budgets To Payments

  9/4/2026

  Global site payments bring lump-sum invoices, multiple languages, and VAT complexity. Discover how streamlined financial workflows reduce risk and delay.

• Debunking 5 Misconceptions About Community-Based Research Sites

  5/28/2025

  By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.

• Partnering For Functional Solutions

  8/1/2025

  We know that functional outsourcing is vital to clinical development today. This is why we build relationships and communicate with you to develop effective solutions.

• Insights From The EACT Clinical Trials Site Personnel Webinar

  2/7/2025

  Collaboration among clinical research stakeholders is breaking financial barriers to support equitable trial access.

• Key Strategies For Clinical Development In Rare Cancers

  2/11/2025

  Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.